Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Omeros Corp reports additional positive phase 1 clinical data for Oms824 for the treatment of cognitive disorders
Omeros Corp reports additional positive phase 1 clinical data for Oms824 for the treatment of cognitive disorders
Omeros Corp reports additional positive phase 1 clinical data for Oms824 for the treatment of cognitive disorders
Submitted by
admin
on February 11, 2014 - 10:38am
Source:
Reuters
News Tags:
Omeros
OMS824
cognitive disorders
Headline:
Omeros Corp reports additional positive phase 1 clinical data for Oms824 for the treatment of cognitive disorders
Do Not Allow Advertisers to Use My Personal information
